INTRODUCTION
Neuroendocrine neoplasms are defined as epithelial neoplasms with predominant neuroendocrine differentiation, which range from non-aggressive carcinoid tumors to highly aggressive small cell carcinomas [1] . Neuroendocrine neoplasms arise in most organs of the body, especially the lungs, pancreas, and gastrointestinal tract [2] .
Since Wade et al. [3] first reported a neuroendocrine tumor in 1983, several cases have been reported. We present a case of a primary neuroendocrine carcinoma of the breast with imaging and pathologic findings.
CASE REPORT
In July 2007, a 64-year-old woman sought evaluation at our hospital for a palpable lesion in the left breast which had been detected several days earlier. The medical history was significant for diabetes mellitus and hypertension. A 0.8-cm irregular, hypoechoic lesion near the left areola was demonstrated on sonography (Fig. 1A) . A biopsy was recommended due to the suspicious shape; however, the patient declined any procedures which would permit pathologic confirmation.
In December 2010, the patient visited our hospital with symptoms of exertional dyspnea of 1 month duration.
Because of the underlying diabetes mellitus and hypertension, the imaging work-up focused on the pulmonary symptoms. A chest computed tomography (CT) showed multiple nodular septa, fissures, and pleural thickening of both lungs with a large bilateral pleural effusion and multiple enlarged lymph nodes in the paratracheal and axillary areas, suggestive of lymphangitic metastasis. There were no pulmonary nodules, mediastinal masses, or bronchial abnormalities. In addition to the pulmonary find- Estrogen and progesterone receptors are expressed in >50% of small cell carcinomas [4] . The histogenesis of primary small cell neuroendocrine carcinomas is still unclear.
It has been suggested that a small cell neuroendocrine carcinoma is a variant of a metaplastic carcinoma arising from usual lobular or ductal carcinoma [4] or multipotential stem cells capable of divergent differentiation [7] .
Breast small cell carcinomas should be differentiated from small cell carcinomas from another site, lobular carcinomas, or lymphomas; immunohistochemistry may help to distinguish such lesions. Breast small cell carcinomas are positive for cytokeratin 7 and negative for cytokeratin 20, whereas pulmonary small cell carcinomas are negative for both markers [4] . E-cadherin is negative in lobular carcinomas, but 100% positive in small cell carcinomas [8] . Lymphomas are immunoreactive for leukocyte common antigen, CD20, or CD3. In the current case, light mi- The serum tumor marker CA15-3 was within normal limit in our case and was not helpful to differentiate the primary lesion. Kinoshita et al. [7] reported elevated levels of serum carcinoembryonic antigen and NCC-ST-439 and Kitakata et al. [9] reported that the levels of the serum tu- 
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